Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment.

International journal of dermatology - 1 Feb 2011

Czajkowski Rafal

Abstract excerpt

BACKGROUND: Cultured pigment cells are increasingly being used in the treatment of stable vitiligo. The melanocyte growth media contain synthetic and human recombinant mitogenic factors. High concentration of growth factors, increased melanin biosynthesis, and the rapid cell cycle progression may lead to the genetic material damage and the initiation of melanocyte malignant transformation in cell culture...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Culture Techniques
Share to Melanocytes
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Tetradecanoylphorbol Acetate

Share to Vitiligo

Source

Identifiers

PMID: 21244382
DOI: 10.1111/j.1365-4632.2010.04675.x

Genes

BRAF
HRAS
KRAS
NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment.PMID 21244382Read ↗

Evaluation of Cultured Melanocytes in Terms of Pigmentation, Genetic Stability and Tumorigenicity in order to Vitiligo patients TransplantationSemantic proximity Read ↗

Comparing Cultured Melanocyte versus melanoma in Terms of Genetic Stability and Tumorigenicity for Vitiligo patient’s treatmentSemantic proximity Read ↗

Molecular cytogenetics of cutaneous melanocytic lesions – diagnostic, prognostic and therapeutic aspectsSemantic proximity Read ↗

Isolation, Culture, and Transfection of MelanocytesSemantic proximity Read ↗

Recent progress in melasma pathogenesis.Semantic proximity Read ↗

Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disordersSemantic proximity Read ↗

Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.Semantic proximity Read ↗

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and TherapySemantic proximity Read ↗

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.Semantic proximity Read ↗

Comparison of responses of melanocyte lineages from p75(+) and p75(-) human scalp-derived neural crest stem cells under phototherapy.Semantic proximity Read ↗

Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell MobilizationSemantic proximity Read ↗

Apoptosis Regulators and Responses in Human Melanocytic and Keratinocytic CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.